Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

4.1K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
4.1K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

3.4K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.4K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

2.5K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.5K
Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

2.1K
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
2.1K
Asthma-I: Introduction01:29

Asthma-I: Introduction

3.8K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.8K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

1.2K
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Pilot Study of the Effect of an Educational Web Application on Asthma Control and Medication Adherence.

The journal of allergy and clinical immunology. In practice·2019
Same author

Feeling Burned Out? Half of Us Are: The Urgent Need to Address Provider Health and Wellness in Allergy and Immunology.

The journal of allergy and clinical immunology. In practice·2017
Same author

Selecting the correct treatment for asthma adherence studies.

The Journal of allergy and clinical immunology·2016
Same author

Asthma adherence management for the clinician.

The journal of allergy and clinical immunology. In practice·2014
Same author

Development and preliminary validation of the Adult Asthma Adherence Questionnaireâ„¢.

The journal of allergy and clinical immunology. In practice·2014
Same author

The potential of asthma adherence management to enhance asthma guidelines.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2011

Related Experiment Video

Updated: Apr 20, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.7K

Improving adherence to asthma therapies.

Andrew G Weinstein

    Current Opinion in Pulmonary Medicine
    |November 22, 2014
    PubMed
    Summary
    This summary is machine-generated.

    Poor adherence to asthma therapies causes significant health issues. A new asthma adherence disease management approach is being tested to identify barriers and improve patient adherence.

    More Related Videos

    Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
    09:42

    Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

    Published on: November 8, 2013

    14.1K
    Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
    07:28

    Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

    Published on: April 6, 2017

    41.8K

    Related Experiment Videos

    Last Updated: Apr 20, 2026

    Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
    14:39

    Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

    Published on: November 4, 2010

    32.7K
    Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
    09:42

    Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

    Published on: November 8, 2013

    14.1K
    Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
    07:28

    Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

    Published on: April 6, 2017

    41.8K

    Area of Science:

    • Pulmonary Medicine
    • Clinical Pharmacy
    • Health Psychology

    Background:

    • Asthma therapy adherence remains a significant challenge, contributing to increased patient morbidity and healthcare resource utilization.
    • Existing strategies to improve adherence have demonstrated limited success in clinical practice.

    Purpose of the Study:

    • To introduce and describe a novel clinical method for enhancing asthma therapy adherence.
    • To outline the components of this new disease management approach for asthma patients.

    Main Methods:

    • The asthma adherence disease management method involves diagnosing adherence status and identifying patient-specific barriers to nonadherence.
    • Clinicians select tailored strategies for each identified barrier, utilizing patient-centered communication skills to maximize effectiveness.
    • This comprehensive approach is currently undergoing evaluation in multiple controlled trials.

    Main Results:

    • The described method offers a structured framework for addressing the complexities of asthma medication adherence.
    • Early indications suggest this patient-centered, barrier-focused strategy holds promise for improving adherence rates.

    Conclusions:

    • Clinicians are encouraged to consider implementing these asthma adherence strategies, either fully or partially.
    • This approach represents a potential advancement in managing asthma and improving patient outcomes through enhanced adherence.